SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-006400
Filing Date
2017-02-07
Accepted
2017-02-07 12:55:32
Documents
1
Group Members
DR. ANAND MEHRA (MEHRA)DR. JAMES I. HEALY (HEALY)DR. MICHAEL F. POWELL (POWELL)SOFINNOVA MANAGEMENT VIII, L.L.C. (SM VIII)

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v458557_sc13da.htm SC 13D/A 104415
  Complete submission text file 0001144204-17-006400.txt   106072
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Subject) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88067 | Film No.: 17578110
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners VIII, L.P. (Filed by) CIK: 0001524064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A